Navigation Links
ChemoCentryx Reports that Traficet-EN Maintains Remission in Crohn's Disease at the Digestive Disease Week (DDW) 2010 Conference
Date:5/4/2010

rop15';s.prop5='External Link';s.eVar3=s.prop5;s.prop15='92776124';s.tl(this,'o','ExternalLink');" target='_blank' href="http://www.chemocentryx.com/">www.chemocentryx.com.

Any statements in this press release about ChemoCentryx's expectations, beliefs, plans, objectives, assumptions or future events or performance are not historical facts and are forward-looking statements. These statements are often, but not always, made through the use of words or phrases such as may, believe, will, expect, anticipate, estimate, intend, predict, seek, potential, continue, plan, should, could and would or the negative of these terms or other comparable terminology. Forward-looking statements are not guarantees of performance. They involve known and unknown risks, uncertainties and assumptions that may cause actual results, levels of activity, performance or achievements to differ materially from any results, levels of activity, performance or achievements expressed or implied by any forward-looking statement. Some of the risks, uncertainties and assumptions that could cause actual results to differ materially from estimates or projections contained in the forward-looking statements include but are not limited to (i) the initiation, timing, progress and results of ChemoCentryx's preclinical studies and clinical trials, (ii) ChemoCentryx's ability to advance product candidates into clinical trials, (iii) GSK's exercise of its license options, (iv) the commercialization of ChemoCentryx's product candidates, (v) the implementation of ChemoCentryx's business model, strategic plans for its business, product candidates and technology, (vi) ChemoCentryx's ability to maintain and establish collaborations or obtain additional government grant funding, (vii) ChemoCentryx's estimates of its expenses, future revenues, capital requirements and its needs for additional financing, (viii) the timing or likelihood of regulatory filings and approvals, (ix) the
'/>"/>

SOURCE ChemoCentryx, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. ChemoCentryx Initiates Clinical Trial of CCR1 Inhibitor CCX354
2. ChemoCentryx Completes Enrollment of PROTECT-1, a Phase II/III Clinical Trial of CCR9 Antagonist CCX282-B (Traficet-EN(TM)) in Crohns Disease
3. PROTECT-1 Phase II/III Induction-Stage Results for ChemoCentryxs Traficet-EN(TM) Presented in Oral Session at DDW 2009 Conference
4. ChemoCentryx Reports Additional New Data from the PROTECT-1 Study Demonstrating Traficet-ENs Effectiveness in Maintaining Remission in Patients with Crohns Disease
5. ChemoCentryx Initiates Clinical Trial of CCX168, A Novel Small Molecule C5aR Antagonist for the Treatment of Inflammatory and Autoimmune Diseases
6. ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference
7. ChemoCentryx Initiates Phase 2 Clinical Trial of CCX354 for the Treatment of Rheumatoid Arthritis
8. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
9. Spherix Reports Second Quarter Earnings
10. Tapestry Reports Second Quarter 2007 Results
11. Callisto Reports on Second-Quarter 2007 Milestones
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/21/2014)... 2014   Auxilium Pharmaceuticals, Inc. (NASDAQ: ... today announced positive results from a randomized, double-blind ... CCH) for the treatment of edematous fibrosclerotic panniculopathy ... 2a trial, all three doses of CCH (low ... improvement in the appearance of cellulite as measured ...
(Date:8/20/2014)... Aug. 20, 2014  The National Association of ... results achieved by the real-time, pseudoephedrine (PSE) blocking ... Precursor Log Exchange (NPLEx), automatically blocks unlawful PSE ... meth offenders and make arrests. Data released by ... blocked the sale of more than ...
(Date:8/20/2014)... The National Association of Drug Diversion ... by the real-time, pseudoephedrine (PSE) blocking system in ... Exchange (NPLEx), automatically blocks unlawful pseudoephedrine sales and ... and make arrests. Data released by NPLEx shows ... blocked the sale of more than 7,481 boxes of ...
Breaking Medicine Technology:Auxilium Pharmaceuticals, Inc. Announces Positive Data From Phase 2a Study Of CCH In Patients With Cellulite 2Auxilium Pharmaceuticals, Inc. Announces Positive Data From Phase 2a Study Of CCH In Patients With Cellulite 3Auxilium Pharmaceuticals, Inc. Announces Positive Data From Phase 2a Study Of CCH In Patients With Cellulite 4Auxilium Pharmaceuticals, Inc. Announces Positive Data From Phase 2a Study Of CCH In Patients With Cellulite 5Auxilium Pharmaceuticals, Inc. Announces Positive Data From Phase 2a Study Of CCH In Patients With Cellulite 6Auxilium Pharmaceuticals, Inc. Announces Positive Data From Phase 2a Study Of CCH In Patients With Cellulite 7Indiana's Stop-Sale System Achieves Significant Results In Battle Against Meth 2Kansas's Stop-Sale System Achieves Significant Results In Battle Against Meth 2
... of Advanced Medical Center, Licensed to ... Administer PROMETA(R), ... use, Dr. Gregory Ellison, Director of Advanced Medical,Center, has identified a ... is performed on an out-patient (versus,in-patient) basis in 10 hours over ...
... Upcoming ECCMID Conference, REINACH, Switzerland, April 11 ... April, Arpida Ltd. (SWX: ARPN) today,elaborates on some ... in complicated Skin and Skin Structure Infections,(cSSSI). Extensive ... year,s ICAAC,and IDSA meetings. Data on ASSIST-2 will ...
Cached Medicine Technology:Arizona Doctor Offers New Addiction Drug Treatment for Meth Addicts Showing More Than 60% Success Rate 2Arizona Doctor Offers New Addiction Drug Treatment for Meth Addicts Showing More Than 60% Success Rate 3Arpida Provides Further Comments on the Pivotal Phase III Trials 2Arpida Provides Further Comments on the Pivotal Phase III Trials 3Arpida Provides Further Comments on the Pivotal Phase III Trials 4
(Date:8/21/2014)... Not only is eating better and exercising healthy for people ... a year, a new study finds. The study, led ... Wake Forest Baptist Medical Center in Winston-Salem, N.C., included ... Participants ranged in age from 45 to ... change program" focused on diet and exercise, or to a ...
(Date:8/21/2014)... HealthDay Reporter THURSDAY, Aug. 21, ... antidepressants appears to best help people with severe but ... of five people suffering from severe depression for less ... cognitive therapy plus antidepressant medication, researchers found. On ... than drugs alone in helping people with mild depression ...
(Date:8/21/2014)... A new study published this week in ... associated with speech problems from 2001-02 to 2010-11 among ... in disability associated with hearing problems. The data underscore ... children who are experiencing communication disorders, according to the ... a broader level, the new study, Changing Trends ...
(Date:8/21/2014)... in rural communities do not routinely screen women ... State medical and public health researchers. Rural women ... resources if they seek help., "Rural health care ... Jennifer S. McCall-Hosenfeld, a primary care physician and ... Penn State College of Medicine. "However, in rural ...
(Date:8/21/2014)... York (PRWEB) August 21, 2014 Xarelto ... thinner caused patients to suffer uncontrollable internal bleeding and ... Bernstein Liebhard LLP reports. According to court documents, a ... U.S. District Court, Easter District of New York by ... to a bleeding event that was allegedly caused by ...
Breaking Medicine News(10 mins):Health News:Getting Healthier a Big Money-Saver for People With Diabetes 2Health News:Talk Therapy Plus Meds May Be Best for Severe Depression 2Health News:Talk Therapy Plus Meds May Be Best for Severe Depression 3Health News:New Pediatrics Study Reveals Dramatic Increase in Speech Problems in Children Over Past Decade 2Health News:New Pediatrics Study Reveals Dramatic Increase in Speech Problems in Children Over Past Decade 3Health News:Primary care physicians can be critical resource for abused women in rural areas 2Health News:Xarelto Lawsuits Mount With New Filing in New York Federal Court, Bernstein Liebhard LLP Reports 2Health News:Xarelto Lawsuits Mount With New Filing in New York Federal Court, Bernstein Liebhard LLP Reports 3Health News:Xarelto Lawsuits Mount With New Filing in New York Federal Court, Bernstein Liebhard LLP Reports 4
... With ... Disabilities, CHICAGO, ... its 27th annual ,Cones for Kids, Valentine,s Day,fundraiser to benefit Easter ... just over $616,000 to help,children and adults with disabilities in 16 ...
... and Company,(NYSE: LLY ) today announced that ... FORSTEO(R) (teriparatide [rDNA origin] injection) for the,treatment of ... and men at increased risk for fracture.,This approval ... by,the Committee for Medicinal Products for Human Use ...
... Milestone Coincides with Visit from Legendary Recording Artist ... The California Science,Center welcomed the 1-millionth visitor ... in what has been a record-breaking run for ... Exposition Park. Grammy,Award-winning recording artist Chaka Khan and ...
... aftereffects reverberate long after the incidents , , THURSDAY, April ... male partner violence suffer a wide range of physical ... study that included 25,000 women in 11 countries. , ... Brazil, Ethiopia, Japan, Namibia, Peru, Samoa, Serbia and Montenegro, ...
... is,pleased to join Harvard University,s Ash Institute for ... bi-annual conference,Frontiers of Innovation: 20 Years of Innovation ... On Monday evening, the executive,director of the Pan ... discussed multisector partnerships in tackling neglected,diseases and in ...
... -- time between births can be risky, research suggests , , THURSDAY, ... When is the right time to have your first child? , ... when to have the next baby -- if you decide to ... say, can decrease your risk of having a baby born premature ...
Cached Medicine News:Health News:Friendly's Dishes Out $616,000 for Easter Seals 2Health News:FORSTEO(R) Receives Approval from the European Commission for the Treatment of Glucocorticoid-Induced Osteoporosis 2Health News:FORSTEO(R) Receives Approval from the European Commission for the Treatment of Glucocorticoid-Induced Osteoporosis 3Health News:FORSTEO(R) Receives Approval from the European Commission for the Treatment of Glucocorticoid-Induced Osteoporosis 4Health News:FORSTEO(R) Receives Approval from the European Commission for the Treatment of Glucocorticoid-Induced Osteoporosis 5Health News:California Science Center Welcomes 1-Millionth BODY WORLDS Visitor 2Health News:Male Partner Violence Hurts Women's Health Worldwide 2Health News:PAHEF Discusses Neglected Diseases and Disaster Preparedness with Innovative Leaders 2Health News:When It Comes to Pregnancy, Timing Is Everything 2Health News:When It Comes to Pregnancy, Timing Is Everything 3
... Tech acclaimed GT-CAPTURE digital camera photomicrographic system ... microscope such as Olympus, Leica, Nikon, and ... and transferring images over the Internet easy ... and a performance-proven Nikkor lens. The system ...
... superb stand-alone digital camera with networking capability ... or remote locations. Image acquisition and camera ... operates independently or attaches directly to a ... to capture and transfer images. Sharing images ...
... are a new generation of flexible CCD cameras, ... video imaging. Images are captured by a high-resolution ... and digital formats. Video signals include composite video, ... to the PC as uncompressed TIFF files. And ...
Console Horizontal Airflow Cabinet...
Medicine Products: